Investigational Alzheimer’s drug improves biomarkers of the disease
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive
Read more
Investigational steroid mirrors prednisone’s benefits while taming its side effects
A head-to-head trial comparing the decades-old steroid, prednisone, and a promising new steroid, vamorolone, finds both act on the same
Read more